Cargando…

General Considerations on the Biosafety of Virus-derived Vectors Used in Gene Therapy and Vaccination

This introductory paper gathers general considerations on the biosafety of virus-derived vectors that are used in human gene therapy and/or vaccination. The importance to assess the potential risks for human health and the environment related to the use of genetically modified organisms (GMO) in thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baldo, Aline, van den Akker, Eric, Bergmans, Hans E., Lim, Filip, Pauwels, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905712/ https://www.ncbi.nlm.nih.gov/pubmed/24195604 http://dx.doi.org/10.2174/15665232113136660005

Ejemplares similares

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
por: Baldo, Aline, et al.
Publicado: (2015)

Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety Considerations
por: Leunda, Amaya, et al.
Publicado: (2014)

Environmental Risk Assessment of Recombinant Viral Vector Vaccines against SARS-Cov-2
por: Baldo, Aline, et al.
Publicado: (2021)

Biosafety Recommendations on the Handling of Animal Cell Cultures
por: Herman, Philippe, et al.
Publicado: (2014)

Retroviral Vector Biosafety: Lessons from Sheep
por: Van den Broeke, Anne, et al.
Publicado: (2003)

Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment
por: Onnockx, Sheela, et al.
Publicado: (2023)

Swinepox virus vector-based vaccines: attenuation and biosafety assessments following subcutaneous prick inoculation
por: Yuan, Xiaomin, et al.
Publicado: (2018)

Current Biosafety Considerations in Stem Cell Therapy
por: Mousavinejad, Masoumeh, et al.
Publicado: (2016)

COVID-19: Postmortem Diagnostic and Biosafety Considerations
por: Lacy, J. Matthew, et al.
Publicado: (2020)

Immunological considerations for laboratory staff and COVID-19 biosafety
por: Kintossou, Ambroise Kouame, et al.
Publicado: (2023)

Laboratory activities involving transmissible spongiform encephalopathy causing agents: Risk assessment and biosafety recommendations in Belgium
por: Leunda, Amaya, et al.
Publicado: (2013)

Biosafety Considerations of Mammalian-Transmissible H5N1 Influenza
por: Imperiale, Michael J., et al.
Publicado: (2012)

Optimization of stimulation parameters for epi-retinal implant based on biosafety consideration
por: Lu, Yijie, et al.
Publicado: (2020)

Treatment of Rheumatoid Arthritis with Gene Therapy Applications: Biosafety and Bioethical Considerations
por: Tsitrouli, Zinovia, et al.
Publicado: (2021)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
por: Robilotti, Elizabeth, et al.
Publicado: (2023)

Biosafety chemistry and biosafety materials: A new perspective to solve biosafety problems
por: Yu, Yingjie, et al.
Publicado: (2022)

Laboratory biosafety for handling emerging viruses
por: Artika, I. Made, et al.
Publicado: (2017)

Biosafety Practices When Working with Bats: A Guide to Field Research Considerations
por: Aguilar-Setién, Alvaro, et al.
Publicado: (2022)

Advanced biosafety materials for prevention and theranostics of biosafety issues
por: Ding, Jianxun, et al.
Publicado: (2022)

Autopsy Biosafety
por: Connolly, Andrew J., et al.
Publicado: (2016)

Biosafety and Bioethics
por: Gupta, Varsha, et al.
Publicado: (2016)

Autopsy Biosafety
por: Finkbeiner, Walter E., et al.
Publicado: (2009)

Animal biosafety
por: Chaplinski, Nick
Publicado: (2016)

Biosafety and biosecurity
por: Zhou, Dongsheng, et al.
Publicado: (2019)

Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
por: Goossens, Martine, et al.
Publicado: (2013)

Biosafety of GM Crop Plants Expressing dsRNA: Data Requirements and EU Regulatory Considerations
por: Arpaia, Salvatore, et al.
Publicado: (2020)

Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities
por: Guo, Ming, et al.
Publicado: (2019)

Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019)

IPR, biosafety, and bioethics
por: Goel, Deepa, et al.
Publicado: (2013)

EHPnet: Genetics and Biosafety
Publicado: (1996)

Biosafety and Biohazards: Understanding Biosafety Levels and Meeting Safety Requirements of a Biobank
por: Ta, Lisa, et al.
Publicado: (2018)

Biosafety considerations and risk reduction strategy for a new veterinary faculty building and teaching hospital in Sweden
por: Wierup, Martin, et al.
Publicado: (2020)

Good laboratory practices guarantee biosafety in the Sierra Leone-China friendship biosafety laboratory
por: Wang, Qin, et al.
Publicado: (2016)

Knowledge Dissemination and Best Practice Transfer on Biosafety, Biosecurity and Biorisk Management Through a Sustainable and Effective Education and Awareness System
por: Argiolas, Carola, et al.
Publicado: (2016)

Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses
por: Chen, Li‐Mei, et al.
Publicado: (2019)

Biosafety in microbiological and biomedical laboratories /
Publicado: (1984)

Grand Challenges for Biosafety and Biosecurity
por: Berns, Kenneth I.
Publicado: (2014)

Recent advances in synthetic biosafety
por: Simon, Anna J., et al.
Publicado: (2016)

Biosafety conducts adopted by orthodontists
por: Monteiro, Camila Gonçalves Jezini, et al.
Publicado: (2018)

Biosafety of Mesoporous Silica Nanoparticles
por: Rascol, Estelle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_90f8ue5t79un41b9nb1nf7i13k